We are live on ! Find out more
AVXL icon

Anavex Life Sciences

145 hedge funds and large institutions have $153M invested in Anavex Life Sciences in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 29

36% more capital invested

Capital invested by funds: $113M → $153M (+$40.2M)

28% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 18

4% more funds holding

Funds holding: 140145 (+5)

2% more call options, than puts

Call options by funds: $4.89M | Put options by funds: $4.79M

0.14% more ownership

Funds ownership: 31.67%31.82% (+0.14%)

Holders
145
Holders Change
+5
Holders Change %
+3.57%
% of All Funds
2.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
23
Increased
48
Reduced
29
Closed
18
Calls
$4.89M
Puts
$4.79M
Net Calls
+$94K
Net Calls Change
-$651K
Name Holding Trade Value Shares
Change
Change in
Stake
FAM
126
Flaharty Asset Management
Florida
$5.68K +$5.77K +1,000 New
BCA
127
Bray Capital Advisors
Florida
$5.4K
HI
128
Harbour Investments
Wisconsin
$4.74K
JPWM
129
Jamison Private Wealth Management
Georgia
$3.98K +$4.04K +700 New
GI
130
GAMMA Investing
California
$3.45K +$2.71K +470 +341%
CA
131
Clearstead Advisors
Ohio
$2.73K
Daiwa Securities Group
132
Daiwa Securities Group
Japan
$2K
PA
133
Parallel Advisors
California
$1.42K
SPIA
134
Steward Partners Investment Advisory
New York
$1.42K
CTA
135
Colonial Trust Advisors
South Carolina
$1.14K
Jones Financial Companies
136
Jones Financial Companies
Missouri
$1.14K
SCM
137
Sterling Capital Management
North Carolina
$1.08K +$1.1K +190 New
SAM
138
Smartleaf Asset Management
Massachusetts
$1.04K +$738 +128 +229%
CPA
139
Capital Performance Advisors
California
$767 +$779 +135 New
RWPA
140
Richard W. Paul & Associates
Michigan
$750
BCMLT
141
Beacon Capital Management LLC (Tennessee)
Tennessee
$625
RIL
142
Rothschild Investment LLC
Illinois
$568 +$231 +40 +67%
FFA
143
Farther Finance Advisors
California
$227
CMP
144
Coston McIsaac & Partners
Maine
$1
YIH
145
Y-Intercept (HK)
Hong Kong
-$399K -94,578 Closed
D.E. Shaw & Co
146
D.E. Shaw & Co
New York
-$246K -58,355 Closed
Marshall Wace
147
Marshall Wace
United Kingdom
-$166K -39,351 Closed
DTL
148
Dynamic Technology Lab
Singapore
-$124K -29,294 Closed
BHCM
149
Brevan Howard Capital Management
Jersey
-$109K -25,801 Closed
Balyasny Asset Management
150
Balyasny Asset Management
Illinois
-$103K -24,349 Closed

AVXL Hedge Fund Activity: Q3 2024 in Review

145 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2024, worth a combined $153M — up 36% from $113M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new AVXL positions and 18 closed out — a net gain of 5 holders — while 48 added to existing stakes and 29 trimmed.

The largest buyer was NWAM LLC, opening a new position worth an estimated $5.25M. The largest seller was State Street, cutting an estimated $3.89M.

  • 145 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2024, up from 140 in Q2 2024.
  • Funds reported $153M of Anavex Life Sciences stock for Q3 2024, up 36% quarter-over-quarter.
  • 23 funds opened new Anavex Life Sciences positions in Q3 2024 and 18 closed out, a net change of +5 holders.
  • The largest Anavex Life Sciences buyer in Q3 2024 was NWAM LLC, an estimated $5.25M added.
  • The largest Anavex Life Sciences seller in Q3 2024 was State Street, an estimated $3.89M sold.

Based on aggregated 13F filings for Q3 2024.